Clinical and neuroimaging features of patients with claustrum sign

ObjectiveThis study aimed at summarizing the clinical and neuroimaging features of patients with claustrum sign, so as to enhance the understanding of this imaging feature and explore its clinical significance.MethodsClinical data from 20 patients with claustrum sign were collected. The clinical cha...

Full description

Saved in:
Bibliographic Details
Main Authors: Chunyan Zhao, Meijiao Zhang, Qingping Zhang, Xinhua Bao
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2025.1589940/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849718234685636608
author Chunyan Zhao
Meijiao Zhang
Qingping Zhang
Xinhua Bao
author_facet Chunyan Zhao
Meijiao Zhang
Qingping Zhang
Xinhua Bao
author_sort Chunyan Zhao
collection DOAJ
description ObjectiveThis study aimed at summarizing the clinical and neuroimaging features of patients with claustrum sign, so as to enhance the understanding of this imaging feature and explore its clinical significance.MethodsClinical data from 20 patients with claustrum sign were collected. The clinical characteristics, neuroimaging evolution, and outcomes were analyzed.ResultsThis cohort included 14 males and 6 females and the median age of onset was 6 years old. Diagnoses included febrile infection-related epilepsy syndrome (FIRES) in 12 cases (60%), antibody-negative autoimmune encephalitis (AbNAE) in 4 (20%), myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) in 3 (15%), and Wilson’s disease (WD) in 1 (5%). Predominant neurological symptoms included seizures (85%) and impaired consciousness (70%). The claustrum sign was observed on days 1–25 (median: day 11.5) after the onset of neurologic symptoms. It presented on the first MRI between days 1 and 14 (median: day 5.5) in 8 cases (40%), while it was absent on the first MRI (days 1–7, median: day 3) in the remaining 12 cases (60%) and appeared on the repeated MRIs (days 6–25, median: day 15). On the follow-up MRIs in 19 cases, the claustrum sign resolved on days 16–132 (median: day 53) in 17 patients, except one with AbNAE and one with WD. The patients with FIRES had the worst prognosis, all developed chronic epilepsy, 75% showed poor memory and calculation, and the median Pediatric Cerebral Performance Category (PCPC) score was 3. In contrast, patients with AbNAE and MOGAD had favorable outcomes with a median PCPC score of 1, respectively.ConclusionThe claustrum sign may represent a transient neuroinflammatory lesion and serve as an imaging marker of neuroinflammation. Lesions in the claustrum can lead to dysfunction of its connected regions, which could be one of the potential mechanisms underlying the high incidence of seizures and the impaired consciousness in children with this imaging feature. Long-term outcomes are closely related to the primary disease.
format Article
id doaj-art-7ec0e526912b49c1b8fb3fa70e618e4c
institution DOAJ
issn 1664-2295
language English
publishDate 2025-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj-art-7ec0e526912b49c1b8fb3fa70e618e4c2025-08-20T03:12:26ZengFrontiers Media S.A.Frontiers in Neurology1664-22952025-05-011610.3389/fneur.2025.15899401589940Clinical and neuroimaging features of patients with claustrum signChunyan ZhaoMeijiao ZhangQingping ZhangXinhua BaoObjectiveThis study aimed at summarizing the clinical and neuroimaging features of patients with claustrum sign, so as to enhance the understanding of this imaging feature and explore its clinical significance.MethodsClinical data from 20 patients with claustrum sign were collected. The clinical characteristics, neuroimaging evolution, and outcomes were analyzed.ResultsThis cohort included 14 males and 6 females and the median age of onset was 6 years old. Diagnoses included febrile infection-related epilepsy syndrome (FIRES) in 12 cases (60%), antibody-negative autoimmune encephalitis (AbNAE) in 4 (20%), myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) in 3 (15%), and Wilson’s disease (WD) in 1 (5%). Predominant neurological symptoms included seizures (85%) and impaired consciousness (70%). The claustrum sign was observed on days 1–25 (median: day 11.5) after the onset of neurologic symptoms. It presented on the first MRI between days 1 and 14 (median: day 5.5) in 8 cases (40%), while it was absent on the first MRI (days 1–7, median: day 3) in the remaining 12 cases (60%) and appeared on the repeated MRIs (days 6–25, median: day 15). On the follow-up MRIs in 19 cases, the claustrum sign resolved on days 16–132 (median: day 53) in 17 patients, except one with AbNAE and one with WD. The patients with FIRES had the worst prognosis, all developed chronic epilepsy, 75% showed poor memory and calculation, and the median Pediatric Cerebral Performance Category (PCPC) score was 3. In contrast, patients with AbNAE and MOGAD had favorable outcomes with a median PCPC score of 1, respectively.ConclusionThe claustrum sign may represent a transient neuroinflammatory lesion and serve as an imaging marker of neuroinflammation. Lesions in the claustrum can lead to dysfunction of its connected regions, which could be one of the potential mechanisms underlying the high incidence of seizures and the impaired consciousness in children with this imaging feature. Long-term outcomes are closely related to the primary disease.https://www.frontiersin.org/articles/10.3389/fneur.2025.1589940/fullclaustrum signneuroinflammationfebrile infection-related epilepsy syndromeautoimmune encephalitismyelin oligodendrocyte glycoprotein antibody-associated diseaseWilson’s disease
spellingShingle Chunyan Zhao
Meijiao Zhang
Qingping Zhang
Xinhua Bao
Clinical and neuroimaging features of patients with claustrum sign
Frontiers in Neurology
claustrum sign
neuroinflammation
febrile infection-related epilepsy syndrome
autoimmune encephalitis
myelin oligodendrocyte glycoprotein antibody-associated disease
Wilson’s disease
title Clinical and neuroimaging features of patients with claustrum sign
title_full Clinical and neuroimaging features of patients with claustrum sign
title_fullStr Clinical and neuroimaging features of patients with claustrum sign
title_full_unstemmed Clinical and neuroimaging features of patients with claustrum sign
title_short Clinical and neuroimaging features of patients with claustrum sign
title_sort clinical and neuroimaging features of patients with claustrum sign
topic claustrum sign
neuroinflammation
febrile infection-related epilepsy syndrome
autoimmune encephalitis
myelin oligodendrocyte glycoprotein antibody-associated disease
Wilson’s disease
url https://www.frontiersin.org/articles/10.3389/fneur.2025.1589940/full
work_keys_str_mv AT chunyanzhao clinicalandneuroimagingfeaturesofpatientswithclaustrumsign
AT meijiaozhang clinicalandneuroimagingfeaturesofpatientswithclaustrumsign
AT qingpingzhang clinicalandneuroimagingfeaturesofpatientswithclaustrumsign
AT xinhuabao clinicalandneuroimagingfeaturesofpatientswithclaustrumsign